Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02214264 · ClinicalTrials.gov registry record · NA

Brief Trainings to Buffer Against Acute Stress Effects

A NA study, sponsored by University of Wisconsin, Madison.

Completed
Registry status
NA
Development phase
172
Enrollment target

NCT02214264: Completed NA study, sponsored by University of Wisconsin, Madison.

NCT02214264 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 172 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02214264, a NA study, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
NA
Development phase
172 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate and compare the effectiveness of several brief trainings based on contemplative practices and positive psychology to buffer against the negative effects that acute stress has on behavior and cognitive abilities. The investigators hypothesize that training will buffer against negative effects of acute stress.

Interventions

  • BEHAVIORAL Gratitude
  • BEHAVIORAL Control
  • BEHAVIORAL Loving-Kindness meditation training
  • BEHAVIORAL Breath Awareness meditation training

Trial Details

FieldValue
Enrollment Target 172 participants
Start Date 2014-10
Est. Completion 2015-05
Phase NA
University of Wisconsin, Madison

1,039 total trials

What the finished NCT02214264 record still lists

NCT02214264 is an interventional study that assigns participants to a tested intervention. The registered 172 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).

The record links to 0 conditions, and to 4 interventions - of which Gratitude is the first listed.

NCT02214264 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02214264 about?

NCT02214264 is a clinical study titled "Brief Trainings to Buffer Against Acute Stress Effects". The purpose of this study is to evaluate and compare the effectiveness of several brief trainings based on contemplative practices and positive psychology to buffer against the negative effects that acute stress has on behavior and cognitive abilities. The investigators hypothesize that training wil...

What is the current status of trial NCT02214264?

This trial is currently completed. It is a NA study. The enrollment target is 172 participants. The study started on 2014-10. Estimated completion is 2015-05.

What interventions are being tested in trial NCT02214264?

The interventions under investigation include: Gratitude (BEHAVIORAL), Control (BEHAVIORAL), Loving-Kindness meditation training (BEHAVIORAL), Breath Awareness meditation training (BEHAVIORAL).

Who is sponsoring clinical trial NCT02214264?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02214264's enrollment target sits among peer trials

172 612th of 2000 higher than 1,389 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04801797 · 172 participants · Phase 2

    Venetoclax + Azacitidine vs. Induction Chemotherapy in AML

  • NCT04867317 · 172 participants · Phase 3

    Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)

  • NCT05357040 · 172 participants · Phase 2

    Antidepressant Effects of Nitrous Oxide

  • NCT05587517 · 172 participants · Phase 2

    A Clinical Trial of Interventions to Support Family Surrogates of Critically Ill Patients

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02214264, the US trial registry maintained by the National Library of Medicine. NCT02214264 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.